Form 4: IGM Biosciences Executive Lisa Decker Sells Shares to Cover Tax Obligations

Lisa Decker, Chief Business Officer of IGM Biosciences, sold 977 shares of common stock on June 14, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On June 14, 2024, Lisa Decker, the Chief Business Officer of IGM Biosciences, sold 977 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $7.5753, with individual trades ranging from $7.26 to $7.94.
• Following the transaction, Decker directly owns 60,029 shares of IGM Biosciences.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to executive compensation and tax obligations, with no inherent positive or negative implications for the company's performance.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. This transaction is a routine disclosure and doesn't necessarily indicate a change in the company's prospects.

Key Dates